Document is current
Any future updates will be listed below
-
Authors
Alosco, Michael L.
Barr, William B.
Banks, Sarah J.
Wethe, Jennifer V.
Miller, Justin B.
Pulukuri, Surya Vamsi
Culhane, Julia
Tripodis, Yorghos
Adler, Charles H.
Balcer, Laura J.
Bernick, Charles
Mariani, Megan L.
Cantu, Robert C.
Dodick, David W.
McClean, Michael D.
Au, Rhoda
Mez, Jesse
Turner, Robert W. II
Palmisano, Joseph N.
Martin, Brett
Hartlage, Kaitlin
Cummings, Jeffrey L.
Reiman, Eric M.
Shenton, Martha E.
Stern, Robert A.
,
Su, Yi
Chen, Kewei
Protas, Hillary
Boker, Connie
Farrer, Lindsay
Helm, Robert
Katz, Douglas I.
Kowall, Neil
Mercier, Gustavo
Otis, James
Weller, Jason
Simkin, Irene
Andino, Alondra
Conneely, Shannon
Diamond, Courtney
Fagle, Tessa
Haller, Olivia
Hunt, Tennyson
Gullotti, Nicole
Mayville, Brian
McLaughlin, Kathleen
Nanna, Mary
Platt, Taylor
Rice, Fiona
Sestak, Madison
Annis, Douglas
Chaisson, Christine
Dixon, Diane B.
Finney, Carolyn
Gallagher, Kerrin
Lu, Jun
Ojo, Emmanuel
Pine, Brittany
Ramachandran, Janani
Bouix, Sylvain
Fitzsimmons, Jennifer
Lin, Alexander P.
Koerte, Inga K.
Pasternak, Ofer
Arciniega, Hector
Billah, Tashrif
Bonke, Elena
Breedlove, Katherine
Coello, Eduardo
Coleman, Michael J.
Jung, Leonhard
Liao, Huijun
Loy, Maria
Rizzoni, Elizabeth
Schultz, Vivian
Silva, Annelise
Vessey, Brynn
Wiegand, Tim L. T.
Ritter, Aaron
Sabbagh, Marwan
de la Cruz, Raelynn
Durant, Jan
Golceker, Morgan
Harmon, Nicolette
Kaylegian, Kaeson
Long, Rachelle
Nance, Christin
Sandoval, Priscilla
Marek, Kenneth L.
Serrano, Andrew
Geda, Yonas
Falk, Bryce
Duffy, Amy
Howard, Marci
Montague, Michelle
Osgood, Thomas
Babcock, Debra
Bellgowan, Patrick
Goldberg, Judith
Wisniewski, Thomas
Kirov, Ivan
Lui, Yvonne
Marmar, Charles
Hasanaj, Lisena
Serrano, Liliana
Al-Kharafi, Alhassan
George, Allan
Martin, Sammie
Riley, Edward
Runge, William
Peskind, Elaine R.
Colasurdo, Elizabeth
Marcus, Daniel S.
Gurney, Jenny
Greenwald, Richard
Johnson, Keith A.
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (K23NS102399, U01NS093334, U01NS093334, U01NS093334, U01NS093334)
National Institutes of Health (RF1NS122854)
National Institute on Aging (K01AG054762, R01AG053798, P30AG019610)
NIGMS (P20GM109025)
Alzheimer’s Disease Drug Discovery Foundation
- License Information
-
More Information
Article History
Received: 2 September 2022
Accepted: 16 December 2022
First Online: 3 January 2023
Declarations
:
: All Participant Evaluation Sites received approval by their respective Institutional Review Boards. All participants provide written informed consent during their baseline and follow-up study visits.
: Not applicable.
: CHA consulted for Avion, CND Life Sciences, Jazz, and Precon Health. LJB is Editor-in-Chief of the <i>Journal of Neuro-Ophthalmology</i> and is a paid consultant to Biogen (Cambridge, MA, USA). CB receives research support from the Ultimate Fighting Championship, Top Rank promotions, Haymon Boxing, Las Vegas Raiders, and Professional Bull Riders. He is a paid consultant for Aurora Concussion Therapy Systems, Inc. (St. Paul, MN). RA is a paid consultant to Biogen (Cambridge, MA, USA) and serves on the Scientific Advisory Board of Signant Health (Blue Bell, PA). WBB provides expert witness testimony in legal cases involving concussion and CTE. DWD reports the following conflicts: consulting: Amgen, CapiThera, Cerecin, Ceruvia Lifesciences, Cooltech, Ctrl M, Allergan, Abbvie, Biohaven, GSK, Lundbeck, Eli Lilly, Novartis, Impel, Satsuma, Theranica, WL Gore, Genentech, Nocira, Perfood, Praxis, Pfizer, AYYA Biosciences, and Revance; honoraria/expense reimbursement/royalties: American Academy of Neurology, Headache Cooperative of the Pacific, MF Med Ed Research, Biopharm Communications, CEA Group Holding Company (Clinical Education Alliance LLC), Teva (speaking), Amgen (speaking), Eli Lilly (speaking), Lundbeck (speaking), Vector psychometric Group, Clinical Care Solutions, CME Outfitters, Curry Rockefeller Group, DeepBench, Global Access Meetings, KLJ Associates, Academy for Continued Healthcare Learning, Majallin LLC, Medlogix Communications, Medica Communications LLC, MJH Lifesciences, Miller Medical Communications, Synapse, WebMD Health/Medscape, Wolters Kluwer, Oxford University Press, and Cambridge University Press; non-profit board membership: American Brain Foundation, American Migraine Foundation, ONE Neurology, Precon Health Foundation, International Headache Society Global Patient Advocacy Coalition, Atria Health Collaborative, Domestic Violence HOPE Foundation/Panfila, CSF Leak Foundation. Research Support: Department of Defense, National Institutes of Health, Henry Jackson Foundation, Sperling Foundation, American Migraine Foundation, and Patient Centered Outcomes Research Institute (PCORI); stock options/shareholder/patents/board of directors: Ctrl M (options), Aural analytics (options), ExSano (options), Palion (options), Healint (options), Theranica (options), Second Opinion/Mobile Health (options), Epien (options/board), Nocira (options), Matterhorn (shares/board), Ontologics (shares/board), King-Devick Technologies (options/board), Precon Health (options/board), AYYA Biosciences (options), Axon Therapeutics (options/board), Cephalgia Group (options/board), and Atria Health (options/salary). Patent 17189376.1-1466:vTitle: Botulinum Toxin Dosage Regimen for Chronic Migraine Prophylaxis (No fee/compensation/royalty). RCC is a Senior Advisor to the NFL Head Neck & Spine Committee; Vice President, National Operating Committee on Standards for Athletic Equipment; and Chair, Scientific Advisory Committee, Co-Founder, and Medical Director, Concussion Legacy Foundation. He is a member of the Medical Science Committee for the National Collegiate Athletic Association Student-Athlete Concussion Injury Litigation, and he receives royalties for published books from Houghton Mifflin Harcourt. JLC has provided consultation to Acadia, Alkahest, AriBio, Avanir, Axsome, Behren Therapeutics, Biogen, Cassava, Cerecin, Cerevel, Cortexyme, EIP Pharma, Eisai, GemVax, Genentech, Green Valley, Grifols, Janssen, Jazz, Karuna, Merck, Novo Nordisk, Otsuka, ReMYND, Resverlogix, Roche, Samumed, Samus, Signant Health, Sunovion, Suven, United Neuroscience, and Unlearn AI pharmaceutical and assessment companies. He owns the copyright of the Neuropsychiatric Inventory. EMR is a compensated scientific advisor for Alkahest, Alzheon, Aural Analytics, Denali, Green Valley, Retromer Therapeutics, and Vaxxinity and a co-founder of ALZPath. RAS is a paid consultant to Biogen (Cambridge, MA, USA). He is a member of the Board of Directors of King-Devick Technologies, Inc. (Chicago, IL, USA), and he receives royalties for published neuropsychological tests from Psychological Assessment Resources, Inc. (Lutz, FL, USA). He is a member of the Medical Science Committee for the National Collegiate Athletic Association Student-Athlete Concussion Injury Litigation. The remaining authors have no conflicts of interest to disclose.
